Výsledky vyhledávání
- 1.CHRASTINOVÁ, L.G; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; CEZNEROVÁ, E.; KOTLÍN, R.; PECHERKOVÁ, P.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; HAVLÍČEK, M.; VÁLKA, J.; HOMOLA , J.; SUTTNAR, J. Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array. Scientific reports. 2023, vol. 13, no. 1, art. no. 12816. ISSN 2045-2322.
- 2.HLAVACKOVA, A.; VYDRA, J.; KOVAROVA, H.; CHRASTINOVA, L.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Significant differences of serum metabolism in acute myeloid leukemia WITH IDH2 mutations. [Prezentováno: EHA-SWG scientific meeting on MDS/MPN/AML: commonalities and differences of myeloid neoplasms. Budapest, 2.11.-4.11.2023.].
- 3.CHRASTINOVÁ, L.; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; VÁLKA, J.; HOMOLA J.; SUTTNAR, J. Aberrant glycosylation patterns in myelodysplastic syndrome: a lectin array study. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 4.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; KOVAROVA, H.; STIKAROVA, J.; SUTTNAR, J. Targeted metabolomic profiling of AML patients: the effect of conditioning regimens on post-transplantation complications. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 5.MALY, M.; RIEDEL, T.; STIKAROVA, J.G; SUTTNAR, J.; KOTLIN, R.; HAJSL, M.; TOUSEK, P.; KAUFMANOVA, J.; KUCERKA, O.; WEISEL, J.W.; DYR, J.E. Incorporation of fibrin, platelets, and red blood cells into a coronary thrombus in time and space. Thrombosis and haemostasis. 2022, vol. 122, no. 3, s. 434-444. ISSN 0340-6245.
- 6.CEZNEROVÁ, E.G; KAUFMANOVÁ, J.; ŠTIKAROVÁ, J.; PASTVA, O.; LOUŽIL, J.; CHRASTINOVÁ, L.; SUTTNAR, J.; KOTLÍN, R.; DYR, J.E. Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications. Blood coagulation & fibrinolysis. 2022, vol. 33, no. 4, s. 228-237. ISSN 0957-5235.
- 7.VALENTA, J.; HLAVACKOVA, A.G; STACH, Z.; STIKAROVA, J.; HAVLICEK, M.; MICHALEK, P. Fibrinogenolysis in venom-induced consumption coagulopathy after Viperidae snakebites: a pilot study. Toxins. 2022, vol. 14, no. 8, art. no. 538. ISSN 2072-6651.
- 8.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Metabolic alterations and elevation of oxidative stress during the early post-transplant period in AML patients. Blood. 2022, vol. 140, no. S1, s. 11833. ISSN 0006-4971.
- 9.CEZNEROVÁ, E.; KAUFMANOVÁ, J.; SOVOVÁ, Ž.; ŠTIKAROVÁ, J.; LOUŽIL, J.; KOTLÍN, R.G; SUTTNAR, J. Structural and functional characterization of four novel fibrinogen mutations in FGB causing congenital fibrinogen disorder. International journal of molecular sciences. 2022, vol. 23, no. 2, art. no. 721. ISSN 1422-0067.
- 10.LOUZIL, J.G; STIKAROVA, J.; PROVAZNIKOVA, D.; HRACHOVINOVA, I.; FENCLOVA, T.; MUSIL, J.; RADEK, M.; KAUFMANOVA, J.; GEIEROVA, V.; CEZNEROVA, E.; SALAJ, P.; KOTLIN, R. Diagnosing Czech patients with inherited platelet disorders. International journal of molecular sciences. 2022, vol. 23, no. 22, art. no. 14386. ISSN 1422-0067.